The central government is preparing a major crackdown on the illegal sale and misuse of sexual enhancement medicines being sold without valid medical prescriptions across the country. India’s drug regulator has warned that the unchecked distribution and consumption of such products pose a serious threat to public health and social safety. With rising misuse, the circulation of counterfeit medicines, and increasing consumption among young people, authorities are now planning stricter surveillance and enforcement measures at the national level. According to official sources, Drugs Controller General of India Dr. Rajeev Singh Raghuvanshi has directed action against unauthorized sexual enhancement products being sold without legitimate prescriptions. The move comes amid growing complaints regarding the large-scale sale of medicines related to erectile dysfunction and premature ejaculation through online platforms, unauthorized medical stores, and illegal clinics.
Risks of Unsupervised Consumption
The Central Drugs Standard Control Organisation has reportedly viewed the issue not merely as a medical concern but also as a social and regulatory challenge. Officials believe the increasing use of such drugs among young consumers is linked to performance anxiety, psychological pressure, and misleading perceptions promoted through social media and digital advertisements. Medical experts have warned that drugs such as sildenafil, tadalafil, vardenafil, and dapoxetine can be dangerous if consumed without professional medical supervision. These medicines affect blood circulation and may trigger severe reactions when combined with other medications. Doctors say uncontrolled consumption may lead to sudden drops in blood pressure, irregular heartbeat, dizziness, and other serious side effects. Health specialists have also identified counterfeit medicines as a major threat. According to experts, many products sold through black markets and unregulated online platforms contain unsafe chemicals or incorrect dosages of active ingredients. Such products may not only cause immediate health complications but could also result in long-term physical damage.
Regulatory Directives and Enforcement Measures
To address the growing problem, the CDSCO has issued a four-point directive to state drug control departments. The measures include conducting raids on illegal clinics, unauthorized pharmacies, and unregulated online platforms. Authorities have also been instructed to work on new legislative measures, train police and enforcement agencies regarding the risks associated with these medicines, and strengthen monitoring of prescription and licensing compliance. Government sources indicate that e-commerce websites and social media channels may also come under tighter surveillance in the coming months. Many products marketed as herbal supplements, energy boosters, or performance support medicines are reportedly being sold openly online. In several cases, consumers purchase such products without realizing that they contain powerful pharmaceutical substances. India’s sexual wellness market has expanded rapidly in recent years and is estimated to be worth more than 9,500 crore. Major pharmaceutical companies operating in this segment include Sun Pharma, Cipla, Mankind Pharma, Zydus Lifesciences, Eli Lilly, Alkem Laboratories, and Dr. Reddy’s Laboratories. However, experts say that for ordinary consumers, distinguishing between genuine medicines and counterfeit products remains extremely difficult.
Expert Warnings on Digital Networks
The issue gained further attention after Rajya Sabha MP Dr. Ajit Madhavrao Gopchade raised concerns regarding the widespread misuse of such medicines among young people seeking confidence enhancement and relief from performance anxiety. He also warned that counterfeit products circulating in the black market pose a significant threat to public health. Renowned cyber and digital crime expert Prof. Triveni Singh stated that illegal online medicine trade is increasingly being operated through organized digital networks using social media advertisements, fake websites, and messaging platforms to target young consumers. He warned that consuming medicines without proper medical advice can lead to serious health risks and advised people to purchase medicines only from licensed pharmacies and authorized medical outlets. The combined efforts of the DCGI and state regulators aim to dismantle these digital networks and ensure that pharmaceutical sales remain within the bounds of strict medical supervision to protect the physical and psychological well-being of the public.
